No Data
No Data
Ekitan: Supplementary explanations for Q1 financial statements for the fiscal year ending March 2025.
Ekitan: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.
Ekitan & Co. Sees 1H Loss Y10.00M
FunPep, EMnet J, etc.
<2497> Establishes United shareholder benefits. <3646> RSP, which is engaged in planning and production of station advertising media, has signed a business partnership agreement with Michi-no-eki. <4169> Records 0.5 billion yen as special profit as insurance payment received by Energy Change. <4881> Starts AI drug discovery research for Fanpep antibody targeting peptides. <4883> Acquires and redeems all of the remaining No.1 unsecured convertible bonds with share subscription rights and No. 12 share subscription rights for unsecured convertible bonds with share subscription rights.
Ekitan: Announcements of individual stocks regarding financial information of unlisted parent companies.
Ekitan: Interim report
No Data
No Data